
Aditi Dutt
Examiner (ID: 4557, Phone: (571)272-9037 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1675 |
| Total Applications | 616 |
| Issued Applications | 219 |
| Pending Applications | 76 |
| Abandoned Applications | 327 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10147900
[patent_doc_number] => 09180165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-10
[patent_title] => 'Use of EPO receptor activation or stimulation for the improvement of the EDSS score in patients with multiple sclerosis'
[patent_app_type] => utility
[patent_app_number] => 12/136509
[patent_app_country] => US
[patent_app_date] => 2008-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13025
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12136509
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/136509 | Use of EPO receptor activation or stimulation for the improvement of the EDSS score in patients with multiple sclerosis | Jun 9, 2008 | Issued |
Array
(
[id] => 10649399
[patent_doc_number] => 09365634
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-14
[patent_title] => 'Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues'
[patent_app_type] => utility
[patent_app_number] => 12/601803
[patent_app_country] => US
[patent_app_date] => 2008-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 40
[patent_no_of_words] => 24208
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12601803
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/601803 | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues | May 28, 2008 | Issued |
Array
(
[id] => 4959668
[patent_doc_number] => 20080274093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'METHOD OF DIMINISHING THE SYMPTOMS OF NEURODEGENERATIVE DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/111709
[patent_app_country] => US
[patent_app_date] => 2008-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10134
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274093.pdf
[firstpage_image] =>[orig_patent_app_number] => 12111709
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/111709 | METHOD OF DIMINISHING THE SYMPTOMS OF NEURODEGENERATIVE DISEASE | Apr 28, 2008 | Abandoned |
Array
(
[id] => 8950555
[patent_doc_number] => 20130196336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'TRANSGLUTAMINASE 6 AS A DIAGNOSTIC INDICATOR OF AUTOIMMUNE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/594926
[patent_app_country] => US
[patent_app_date] => 2008-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13929
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12594926
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/594926 | TRANSGLUTAMINASE 6 AS A DIAGNOSTIC INDICATOR OF AUTOIMMUNE DISEASES | Apr 6, 2008 | Abandoned |
Array
(
[id] => 159704
[patent_doc_number] => 07674890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-09
[patent_title] => 'Stem cell factor-like proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/080212
[patent_app_country] => US
[patent_app_date] => 2008-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 35300
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/674/07674890.pdf
[firstpage_image] =>[orig_patent_app_number] => 12080212
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/080212 | Stem cell factor-like proteins and uses thereof | Mar 31, 2008 | Issued |
Array
(
[id] => 10045365
[patent_doc_number] => 09085754
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-21
[patent_title] => 'Isolated population of cells and methods of generating and using same'
[patent_app_type] => utility
[patent_app_number] => 12/450515
[patent_app_country] => US
[patent_app_date] => 2008-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 12
[patent_no_of_words] => 12172
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12450515
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/450515 | Isolated population of cells and methods of generating and using same | Mar 26, 2008 | Issued |
Array
(
[id] => 4765114
[patent_doc_number] => 20080176325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Method for Obtaining and Storing Multipotent Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 12/047563
[patent_app_country] => US
[patent_app_date] => 2008-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3433
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176325.pdf
[firstpage_image] =>[orig_patent_app_number] => 12047563
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/047563 | Method for Obtaining and Storing Multipotent Stem Cells | Mar 12, 2008 | Abandoned |
Array
(
[id] => 4740544
[patent_doc_number] => 20080234197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Method(s) of stabilizing and potentiating the actions and administration of brain-derived neurotrophic factor (BDNF)'
[patent_app_type] => utility
[patent_app_number] => 12/075084
[patent_app_country] => US
[patent_app_date] => 2008-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12536
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234197.pdf
[firstpage_image] =>[orig_patent_app_number] => 12075084
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/075084 | Method(s) of stabilizing and potentiating the actions and administration of brain-derived neurotrophic factor (BDNF) | Mar 9, 2008 | Abandoned |
Array
(
[id] => 4848
[patent_doc_number] => 07812126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-12
[patent_title] => 'DIRS1 polypeptides'
[patent_app_type] => utility
[patent_app_number] => 12/042165
[patent_app_country] => US
[patent_app_date] => 2008-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22489
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/812/07812126.pdf
[firstpage_image] =>[orig_patent_app_number] => 12042165
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/042165 | DIRS1 polypeptides | Mar 3, 2008 | Issued |
Array
(
[id] => 4821965
[patent_doc_number] => 20080227201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'In vitro model for neuronal death'
[patent_app_type] => utility
[patent_app_number] => 12/013921
[patent_app_country] => US
[patent_app_date] => 2008-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7742
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227201.pdf
[firstpage_image] =>[orig_patent_app_number] => 12013921
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/013921 | In vitro model for neuronal death | Jan 13, 2008 | Issued |
Array
(
[id] => 10881991
[patent_doc_number] => 08906367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-09
[patent_title] => 'Method of providing disease-specific binding molecules and targets'
[patent_app_type] => utility
[patent_app_number] => 12/522031
[patent_app_country] => US
[patent_app_date] => 2008-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 22
[patent_no_of_words] => 43430
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12522031
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/522031 | Method of providing disease-specific binding molecules and targets | Jan 6, 2008 | Issued |
Array
(
[id] => 6398039
[patent_doc_number] => 20100178652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-15
[patent_title] => 'Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease'
[patent_app_type] => utility
[patent_app_number] => 12/522155
[patent_app_country] => US
[patent_app_date] => 2008-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14083
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20100178652.pdf
[firstpage_image] =>[orig_patent_app_number] => 12522155
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/522155 | Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease | Jan 6, 2008 | Abandoned |
Array
(
[id] => 6251691
[patent_doc_number] => 20100028297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'COADMINISTRATION OF ALPHA-FETOPROTEIN AND AN IMMUNOMODULATORY AGENT TO TREAT MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 12/520045
[patent_app_country] => US
[patent_app_date] => 2007-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 16575
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028297.pdf
[firstpage_image] =>[orig_patent_app_number] => 12520045
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/520045 | COADMINISTRATION OF ALPHA-FETOPROTEIN AND AN IMMUNOMODULATORY AGENT TO TREAT MULTIPLE SCLEROSIS | Dec 18, 2007 | Abandoned |
Array
(
[id] => 6574009
[patent_doc_number] => 20100129319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'TREATMENT OF DISEASE OR INJURY OF THE NERVOUS SYSTEM USING AGENTS THAT DECREASE THE ACTIVITY OF THE MELANOCORTIN 4 RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 12/518761
[patent_app_country] => US
[patent_app_date] => 2007-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14981
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129319.pdf
[firstpage_image] =>[orig_patent_app_number] => 12518761
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/518761 | TREATMENT OF DISEASE OR INJURY OF THE NERVOUS SYSTEM USING AGENTS THAT DECREASE THE ACTIVITY OF THE MELANOCORTIN 4 RECEPTOR | Dec 13, 2007 | Abandoned |
Array
(
[id] => 6631064
[patent_doc_number] => 20100035286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'IN VITRO METHOD FOR THE DIAGNOSIS AND EARLY DIAGNOSIS OF NEURODEGENERATIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/516851
[patent_app_country] => US
[patent_app_date] => 2007-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4567
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035286.pdf
[firstpage_image] =>[orig_patent_app_number] => 12516851
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/516851 | IN VITRO METHOD FOR THE DIAGNOSIS AND EARLY DIAGNOSIS OF NEURODEGENERATIVE DISORDERS | Nov 27, 2007 | Abandoned |
Array
(
[id] => 5277887
[patent_doc_number] => 20090130019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Methods of perispinal extrathecal administration of large molecules for diagnostic use in mammals'
[patent_app_type] => utility
[patent_app_number] => 11/986423
[patent_app_country] => US
[patent_app_date] => 2007-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22128
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130019.pdf
[firstpage_image] =>[orig_patent_app_number] => 11986423
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/986423 | Methods of perispinal extrathecal administration of large molecules for diagnostic use in mammals | Nov 20, 2007 | Abandoned |
Array
(
[id] => 6588724
[patent_doc_number] => 20100061992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'THERAPEUTIC USES OF TIM-3 MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 12/514602
[patent_app_country] => US
[patent_app_date] => 2007-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 35441
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20100061992.pdf
[firstpage_image] =>[orig_patent_app_number] => 12514602
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/514602 | THERAPEUTIC USES OF TIM-3 MODULATORS | Nov 14, 2007 | Abandoned |
Array
(
[id] => 4746166
[patent_doc_number] => 20080090768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 11/930104
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 19386
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20080090768.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930104
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930104 | RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE | Oct 30, 2007 | Abandoned |
Array
(
[id] => 4786145
[patent_doc_number] => 20080139474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 11/930057
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 19381
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139474.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930057
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930057 | RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE | Oct 29, 2007 | Abandoned |
Array
(
[id] => 4922526
[patent_doc_number] => 20080070842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 11/930082
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 19384
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070842.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930082
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930082 | RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE | Oct 29, 2007 | Abandoned |